A study recently published in BJUI Compass found that Unfold AI, an FDA-cleared artificial intelligence algorithm developed by Avenda Health, accurately predicted extracapsular extension risk (ECE) and outperformed conventional methodologies.
We are at a transformational period in oncology; the overall mortality from cancer is gradually declining in the United States.
